Stockreport

ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company

IMMUNOCELLULAR THRPTS NEW  (IMUC) 
NASDAQ:AMEX Investor Relations: investors.imuc.com